TransMedics Group, Inc.

NasdaqGM:TMDX Rapporto sulle azioni

Cap. di mercato: US$5.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

TransMedics Group Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Waleed Hassanein

Amministratore delegato

US$6.8m

Compenso totale

Percentuale dello stipendio del CEO9.4%
Mandato del CEO26yrs
Proprietà del CEO1.4%
Durata media del management5.4yrs
Durata media del Consiglio di amministrazione11yrs

Aggiornamenti recenti sulla gestione

Recent updates

TransMedics: Heart And Lungs Will Drive The Next Leg Higher

Aug 19

Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy

Aug 04

TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 02
TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

TransMedics Group Stock: Too Far, Too Fast

Jul 08

TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey

Jun 17

TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

Jun 10
TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

TransMedics: Transportation Supporting Growth

May 21

TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)

May 06

TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 24
TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

TransMedics Group: Founder Led Company With Solid Potential

Apr 19

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 11
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway

Mar 19

TransMedics Group: Huge Opportunity In Organ Transplants

Mar 12

TransMedics: A Very Expensive Growth Stock

Feb 07

With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Jan 23
With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Jan 02
Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

Nov 05
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

Aug 06
This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

Aug 02
TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Jun 29
TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

May 06
Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 27
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Apr 09
Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

Jan 16
Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Waleed Hassanein rispetto agli utili di TransMedics Group?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

US$3m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$7mUS$634k

-US$25m

Sep 30 2023n/an/a

-US$36m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023n/an/a

-US$28m

Dec 31 2022US$3mUS$575k

-US$36m

Sep 30 2022n/an/a

-US$42m

Jun 30 2022n/an/a

-US$48m

Mar 31 2022n/an/a

-US$47m

Dec 31 2021US$7mUS$535k

-US$44m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$30m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020US$2mUS$534k

-US$29m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$36m

Dec 28 2019US$3mUS$449k

-US$34m

Sep 28 2019n/an/a

-US$32m

Jun 29 2019n/an/a

-US$29m

Mar 30 2019n/an/a

-US$26m

Dec 29 2018US$524kUS$384k

-US$24m

Sep 29 2018n/an/a

-US$21m

Jun 30 2018n/an/a

-US$20m

Mar 31 2018n/an/a

-US$20m

Dec 30 2017US$601kUS$351k

-US$21m

Compensazione vs Mercato: La retribuzione totale di Waleed ($USD 6.76M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 8.39M ).

Compensazione vs guadagni: La retribuzione di Waleed è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Waleed Hassanein (56 yo)

26yrs

Mandato

US$6,758,070

Compensazione

Dr. Waleed H. Hassanein, M.D. is the Founder of Transmedics Group, Inc. and has been its President, Chief Executive Officer and Director since August 1998. He Founded TransMedics, Inc. in August 1998 and h...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Waleed Hassanein
Founder26yrsUS$6.76m1.41%
$ 82.4m
Stephen Gordon
CFO, Treasurer & Secretary9.4yrsUS$2.64m0.064%
$ 3.7m
Nicholas Corcoran
Senior Vice President of Supply Chain & Operations1.6yrsUS$2.52m0.0097%
$ 566.1k
Anil Ranganath
Senior VP1.1yrsUS$2.35m0.027%
$ 1.6m
Tamer Khayal
Chief Commercial Officer18.6yrsUS$2.63m0.062%
$ 3.7m
Mark Anderson
Senior Director of Technology Development5.6yrsNessun datoNessun dato
Susan Goodman
Vice President of Human Resources3.4yrsNessun datoNessun dato
Miriam Provost
Vice President of Global Regulatory Affairs5.2yrsUS$813.47kNessun dato

5.4yrs

Durata media

56yo

Età media

Gestione esperta: Il team dirigenziale di TMDX è esperto e expertise (durata media dell'incarico 5.4 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Waleed Hassanein
Founder26yrsUS$6.76m1.41%
$ 82.4m
Edwin Kania
Independent Director21.6yrsUS$220.28k0.91%
$ 53.4m
Merilee Raines
Independent Director3.6yrsUS$238.62k0.0036%
$ 209.8k
James Tobin
Independent Chairman13.6yrsUS$262.32k0.52%
$ 30.6m
Edward Zavala
Member of Advisory Boardno dataNessun datoNessun dato
Gayle Winters
Member of Advisory Boardno dataNessun datoNessun dato
Ryszard Smolenski
Member of Advisory Boardno dataNessun datoNessun dato
Bruce Rosengard
Member of Advisory Boardno dataNessun datoNessun dato
Scott D. Solomon
Member of Advisory Boardno dataNessun datoNessun dato
Robert Kormos
Member of Advisory Boardno dataNessun datoNessun dato
Edward Basile
Independent Director8.5yrsUS$232.26k0.0022%
$ 128.3k
Thomas Gunderson
Independent Director8yrsUS$237.74k0.0036%
$ 209.8k

11.0yrs

Durata media

70.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di TMDX è composto da personale esperto e esperto (durata media dell'incarico 11 anni).